Serum KIM-1 Emerges as Potential Biomarker to Guide Adjuvant Immunotherapy in High-Risk Resected RCC - OncLive
Serum KIM-1 Emerges as Potential Biomarker to Guide Adjuvant Immunotherapy in High-Risk Resected RCC OncLive ...
Serum,KIM-1,Emerges,as,Potential,Biomarker,to,Guide,Adjuvant,Immunotherapy